Landaas & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,786
| Closed | -$225K | – | 82 |
|
|
2023
Q3 | $225K | Buy |
6,786
+27
| +0.4% | +$895 | 0.1% | 66 |
|
|
2023
Q2 | $248K | Hold |
6,759
| – | – | 0.11% | 61 |
|
|
2023
Q1 | $276K | Hold |
6,759
| – | – | 0.13% | 50 |
|
|
2022
Q4 | $346K | Hold |
6,759
| – | – | 0.19% | 37 |
|
|
2022
Q3 | $296K | Hold |
6,759
| – | – | 0.19% | 41 |
|
|
2022
Q2 | $354K | Hold |
6,759
| – | – | 0.22% | 40 |
|
|
2022
Q1 | $399K | Hold |
6,759
| – | – | 0.21% | 42 |
|
|
2021
Q4 | $399K | Hold |
6,759
| – | – | 0.21% | 42 |
|
|
2021
Q3 | $291K | Sell |
6,759
-370
| -5% | -$15.9K | 0.17% | 49 |
|
|
2021
Q2 | $279K | Hold |
7,129
| – | – | 0.16% | 52 |
|
|
2021
Q1 | $258K | Hold |
7,129
| – | – | 0.15% | 58 |
|
|
2020
Q4 | $262K | Sell |
7,129
-314
| -4% | -$11.5K | 0.18% | 48 |
|
|
2020
Q3 | $259K | Sell |
7,443
-506
| -6% | -$17.6K | 0.2% | 46 |
|
|
2020
Q2 | $247K | Hold |
7,949
| – | – | 0.2% | 46 |
|
|
2020
Q1 | $275K | Sell |
7,949
-137
| -2% | -$4.74K | 0.23% | 44 |
|
|
2019
Q4 | $301K | Sell |
8,086
-211
| -3% | -$7.85K | 0.21% | 46 |
|
|
2019
Q3 | $283K | Hold |
8,297
| – | – | 0.21% | 44 |
|
|
2019
Q2 | $341K | Sell |
8,297
-1,163
| -12% | -$47.8K | 0.24% | 39 |
|
|
2019
Q1 | $381K | Sell |
9,460
-273
| -3% | -$11K | 0.28% | 35 |
|
|
2018
Q4 | $403K | Buy |
9,733
+2
| +0% | +$83 | 0.33% | 32 |
|
|
2018
Q3 | $407K | Buy |
9,731
+2
| +0% | +$84 | 0.32% | 35 |
|
|
2018
Q2 | $335K | Buy |
9,729
+530
| +6% | +$18.3K | 0.27% | 38 |
|
|
2018
Q1 | $310K | Sell |
9,199
-37
| -0.4% | -$1.25K | 0.31% | 36 |
|
|
2017
Q4 | $317K | Buy |
9,236
+2
| +0% | +$69 | 0.27% | 37 |
|
|
2017
Q3 | $313K | Buy |
+9,234
| New | +$313K | 0.28% | 42 |
|